Concentra Group
CON
36.40
0.00
0.00%
Concentra Group
US · CON
#2185 by market cap
Listed 2024
36.40
0.00
0.00%
Live - 5344 symbols - heartbeat 102s ago
· 2026-10-08 08:29
Pre-market
36.26
-0.38%
After-hours
36.40
0.00%
- Market cap
- 4.64B
- P/E (TTM)i
- 23.48
- P/Bi
- 9.73
- EPSi
- 1.30
- Div yieldi
- 0.69%
- 52W posi
- 98%
Reader sentiment
Are you bullish or bearish on CON?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.38, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +13.85% YoY
Margins
- Gross margin
- 28.34%
- Operating margin
- 15.44%
- Net margin
- 7.69%
Key ratios & quality
- Enterprise valuei
- 6.22B
- Altman Z-Scorei
- 2.38
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.73B | 1.72B | 1.84B | 1.90B | 2.16B |
| Gross profit | 510.19M | 481.86M | 512.43M | 527.98M | 613.09M |
| Selling & admin expenses | 157.71M | 149.98M | 152.00M | 156.32M | 203.31M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | 305.26M | 258.53M | 287.63M | 304.76M | 333.99M |
| Pretax profit | 275.56M | 224.90M | 242.63M | 231.39M | 223.83M |
| Tax | 59.53M | 52.65M | 57.89M | 59.50M | 50.98M |
| Net profit | 216.04M | 172.24M | 184.74M | 171.90M | 172.85M |
| Basic EPS | 2 | 1 | 1 | 1 | 1 |
| Diluted EPS | 1.65 | 1.32 | 1.42 | 1.46 | 1.30 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 500.75M | 550.79M | 572.80M | 539.08M | 569.56M | 606.03M |
| Gross profit | 143.65M | 161.45M | 167.27M | 140.73M | 170.47M | 192.10M |
| Selling & admin expenses | 46.71M | 52.93M | 52.88M | 50.78M | 55.28M | 56.68M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 80.32M | 89.54M | 94.47M | 69.66M | 95.61M | 115.07M |
| Pretax profit | 53.90M | 61.35M | 65.79M | 42.79M | 69.61M | 89.35M |
| Tax | 13.25M | 15.16M | 15.97M | 6.60M | 17.32M | 22.05M |
| Net profit | 40.64M | 46.19M | 49.82M | 36.19M | 52.29M | 67.30M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.30 | 0.35 | 0.38 | 0.27 | 0.39 | 0.51 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | -- | 284.63M | 294.42M | 437.21M | 383.10M |
| Cash & ST investments | -- | 37.66M | 31.37M | 183.26M | 79.90M |
| Inventory | -- | -- | -- | -- | -- |
| Total assets | -- | 2.30B | 2.33B | 2.52B | 2.86B |
| Total current liabilities | -- | 279.63M | 274.63M | 307.19M | 337.25M |
| Short-term debt | -- | 72.97M | 74.40M | 85.54M | 95.32M |
| Long-term debt | -- | 633.91M | 473.29M | 1.47B | 1.56B |
| Total liabilities | -- | 1,301,120,000.00 | 1,156,121,000.00 | 2,222,440,000.00 | 2,437,959,000.00 |
| Total equity | -- | 996.12M | 1.18B | 298.72M | 420.43M |
| Retained earnings | -- | -- | -- | 13.55M | 146.45M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 351.59M | 395.17M | 375.44M | 383.10M | 404.21M | 506.48M |
| Cash & ST investments | 52.11M | 73.87M | 49.94M | 79.90M | 61.70M | 158.04M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.73B | 2.84B | 2.84B | 2.86B | 2.89B | 3.01B |
| Total current liabilities | 320.39M | 335.07M | 312.65M | 337.25M | 320.88M | 367.94M |
| Short-term debt | 112.06M | 97.20M | 95.74M | 95.32M | 98.92M | 99.62M |
| Long-term debt | 1.62B | 1.65B | 1.60B | 1.56B | 1.56B | 1.56B |
| Total liabilities | 2,398,177,000.00 | 2,474,204,000.00 | 2,433,797,000.00 | 2,437,959,000.00 | 2,435,790,000.00 | 2,503,851,000.00 |
| Total equity | 331.06M | 367.38M | 410.13M | 420.43M | 453.97M | 506.42M |
| Retained earnings | 44.45M | 79.83M | 120.08M | 146.45M | 186.85M | 244.15M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 290.64M | 274.34M | 234.32M | 274.68M | 279.40M |
| Depreciation & amortization | 82.21M | 73.67M | 73.05M | 67.18M | 75.82M |
| Free cash flow | 243.85M | 228.35M | 164.98M | 210.35M | 197.06M |
| Dividends paid | -- | 0 | 0 | -1.54B | -32.08M |
| Stock buybacks / issuance | 0 | -29.05M | -5.32M | 495.80M | -22.42M |
| Ending cash balance | 30.93M | 37.66M | 31.37M | 183.26M | 79.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 11.70M | 88.38M | 60.63M | 118.69M | 21.02M | 135.21M |
| Depreciation & amortization | 16.62M | 19.00M | 19.91M | 20.29M | 19.65M | 19.90M |
| Free cash flow | -4.03M | 63.15M | 39.42M | 98.52M | 9.93M | 119.55M |
| Dividends paid | 0 | -16.02M | -8.01M | -8.05M | -8.02M | -7.99M |
| Stock buybacks / issuance | 0 | 0 | 0 | -22.42M | -15.00M | -10.96M |
| Ending cash balance | 52.11M | 73.87M | 49.94M | 79.90M | 61.70M | 158.04M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | 17.13 | 11.99 | 23.27 | 49.75 |
| ROA %i | -- | 7.26 | 5.51 | 6.86 | 6.19 |
| ROIC %i | -- | 9.49 | 10.53 | 10.18 | 10.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.75 | 14.88 | 15.60 | 15.85 | 15.40 |
| FCF / sales %i | 14.08 | 13.24 | 8.98 | 11.07 | 9.11 |
| Current ratioi | -- | 1.02 | 1.07 | 1.42 | 1.14 |
| Quick ratioi | -- | 0.87 | 0.90 | 1.31 | 1.00 |
| Debt / assetsi | -- | 45.26 | 38.78 | 77.40 | 73.56 |
| LT debt / equityi | -- | 99.32 | 71.88 | 676.83 | 510.40 |
| Interest coveragei | 9.65 | 8.11 | 2.51 | 4.32 | 3.05 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 3.14 | 7.85 |
| Net income CAGR (3Y) %i | -- | -- | -- | -7.27 | -0.06 |
| FCF CAGR (3Y) %i | -- | -- | -- | -4.81 | -4.79 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 57.19 | 18.67 | 45.74 | 49.75 | 48.48 | 48.13 |
| ROA %i | 6.06 | 5.70 | 5.70 | 6.19 | 6.31 | 6.74 |
| ROIC %i | 9.52 | 9.74 | 9.81 | 10.62 | 10.50 | 10.88 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.78 | 15.66 | 15.44 | 15.40 | 15.65 | 16.39 |
| FCF / sales %i | 9.25 | 9.32 | 8.40 | 9.11 | 9.45 | 11.69 |
| Current ratioi | 1.10 | 1.18 | 1.20 | 1.14 | 1.26 | 1.38 |
| Quick ratioi | 0.97 | 1.03 | 1.05 | 1.00 | 1.12 | 1.24 |
| Debt / assetsi | 78.28 | 76.71 | 75.18 | 73.56 | 73.45 | 71.22 |
| LT debt / equityi | 659.15 | 607.77 | 529.81 | 510.40 | 476.49 | 428.47 |
| Interest coveragei | 3.58 | 3.02 | 2.96 | 3.05 | 3.18 | 3.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:29:04 · For reference only, not investment advice and not tailored to your situation.